Liontrust Investment Partners’s CME Group CME Stock Holding History

Liontrust Investment Partners’s Portfolio CME Stock Details CME Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-207,000	Closed	-$34.8M	–	204
2022 Q4	$34.8M	Hold	207,000	–	–	0.61%	38
2022 Q3	$36.7M	Sell	207,000 -3,000	-1%	-$593K	0.59%	36
2022 Q2	$43M	Buy	210,000 +2,500	+1%	+$530K	0.61%	38
2022 Q1	$49.4M	Sell	207,500 -71,500	-26%	-$16.8M	0.65%	35
2021 Q4	$63.7M	Buy	279,000 +50,500	+22%	+$11.1M	0.76%	33
2021 Q3	$44.2M	Buy	+228,500	New	+$46.3M	0.61%	35
2020 Q4	$38.6M	Buy	+212,000	New	+$36.1M	0.78%	36

Other funds holding CME

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Parnassus Investments San Francisco, California $34.1B AUM 20.22% 1-Year Est. Return

Liontrust Investment Partners's CME Position: Q1 2023 in Review

Liontrust Investment Partners sold out of CME Group (CME) in Q1 2023, closing a stake of 207,000 shares — an estimated $34.8M sold.

Liontrust Investment Partners first reported a position in CME in Q4 2020 and held it in 7 quarters. The position peaked at $63.7M in Q4 2021. 1,171 funds tracked by Wall St. Rank hold CME as of Q1 2023.

Liontrust Investment Partners reported no remaining CME Group position as of Q1 2023 after selling out during the quarter.
Liontrust Investment Partners sold 207,000 CME Group shares in Q1 2023, an estimated $34.8M.
Liontrust Investment Partners first reported a position in CME Group in Q4 2020 and held it in 7 quarters.
Liontrust Investment Partners's CME Group position peaked at $63.7M in Q4 2021.
1,171 funds tracked by Wall St. Rank held CME Group as of Q1 2023.

Based on Liontrust Investment Partners's 13F filing for Q1 2023, filed 15 May 2023.